Related references
Note: Only part of the references are listed.Pegylated Liposomal Doxorubicin, Rituximab, Cyclophosphamide, Vincristine, and Prednisone in AIDS-Related Lymphoma: AIDS Malignancy Consortium Study 047
Alexandra M. Levine et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Pooled analysis of AIDS malignancy consortium trials evaluating rituximab plus CHOP or infusional EPOCH chemotherapy in HIV-associated non-Hodgkin lymphoma
Stefan K. Barta et al.
CANCER (2012)
Selective Inhibition of HER2-Positive Breast Cancer Cells by the HIV Protease Inhibitor Nelfinavir
Joong Sup Shim et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
Mortality after cancer diagnosis in HIV-infected individuals treated with antiretroviral therapy
Chad J. Achenbach et al.
AIDS (2011)
Viremia Copy-Years Predicts Mortality Among Treatment-Naive HIV-Infected Patients Initiating Antiretroviral Therapy
Michael J. Mugavero et al.
CLINICAL INFECTIOUS DISEASES (2011)
Timing of Initiation of Antiretroviral Therapy in Human Immunodeficiency Virus (HIV)-Associated Tuberculous Meningitis
M. Estee Toeroek et al.
CLINICAL INFECTIOUS DISEASES (2011)
Integration of Antiretroviral Therapy with Tuberculosis Treatment
Salim S. Abdool Karim et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Earlier versus Later Start of Antiretroviral Therapy in HIV-Infected Adults with Tuberculosis
Francois-Xavier Blanc et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Timing of Antiretroviral Therapy for HIV-1 Infection and Tuberculosis
Diane V. Havlir et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Survival of non-Hodgkin lymphoma patients with and without HIV infection in the era of combined antiretroviral therapy
Chun Chao et al.
AIDS (2010)
Copy-Years Viremia as a Measure of Cumulative Human Immunodeficiency Virus Viral Burden
Stephen R. Cole et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2010)
Rituximab plus concurrent infusional EPOCH chemotherapy is highly effective in HIV-associated B-cell non-Hodgkin lymphoma
Joseph A. Sparano et al.
BLOOD (2010)
The role of tumor histogenesis, FDG-PET, and short-course EPOCH with dose-dense rituximab (SC-EPOCH-RR) in HIV-associated diffuse large B-cell lymphoma
Kieron Dunleavy et al.
BLOOD (2010)
Cancer as a Cause of Death among People with AIDS in the United States
Edgar P. Simard et al.
CLINICAL INFECTIOUS DISEASES (2010)
Changes in Cancer Mortality among HIV-Infected Patients: The Mortalite 2005 Survey
Fabrice Bonnet et al.
CLINICAL INFECTIOUS DISEASES (2009)
Lymphoma After Solid Organ Transplantation: Risk, Response to Therapy, and Survival at a Transplantation Center
Jason S. Knight et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Early Antiretroviral Therapy Reduces AIDS Progression/Death in Individuals with Acute Opportunistic Infections: A Multicenter Randomized Strategy Trial
Andrew R. Zolopa et al.
PLOS ONE (2009)
Cohort profile: The Centers for AIDS Research Network of Integrated Clinical Systems
Mari M. Kitahata et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2008)
Gene expression profiling of Epstein-Barr virus-positive and -negative monomorphic B-cell posttransplant lymphoproliferative disorders
Fiona E. Craig et al.
DIAGNOSTIC MOLECULAR PATHOLOGY (2007)
HIV protease inhibitor nelfinavir inhibits growth of human melanoma cells by induction of cell cycle arrest
Wei Jiang et al.
CANCER RESEARCH (2007)
NFV, an HIV-1 protease inhibitor, induces growth arrest, reduced Akt signalling, apoptosis and docetaxel sensitisation in NSCLC cell lines
Y. Yang et al.
BRITISH JOURNAL OF CANCER (2006)
Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS-Malignancies Consortium Trial 010
LD Kaplan et al.
BLOOD (2005)
Extended antiretroviral treatment interruption in HIV-infected patients with long-term suppression of plasma HIV RNA
CJ Achenbach et al.
HIV MEDICINE (2005)
Highly effective treatment of acquired immunodeficiency syndrome-related lymphoma with dose-adjusted EPOCH: impact of antiretroviral therapy suspension and tumor biology
RF Little et al.
BLOOD (2003)
Modulation of apoptosis by HIV protease inhibitors
BN Phenix et al.
APOPTOSIS (2002)
Antiapoptotic mechanism of HIV protease inhibitors: preventing mitochondrial transmembrane potential loss
BN Phenix et al.
BLOOD (2001)
HIV dynamics and T-cell immunity after three structured treatment interruptions in chronic HIV-1 infection
L Ruiz et al.
AIDS (2001)
The virological and immunological consequences of structured treatment interruptions in chronic HIV-1 infection
F García et al.
AIDS (2001)
Pre-HAART HIV burden approximates post-HAART viral levels following interruption of therapy in patients with sustained viral suppression
H Hatano et al.
AIDS (2000)
Epstein-Barr virus-negative post-transplant lymphoproliferative disorders - A distinct entity?
BP Nelson et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2000)
Share Paper
